Financial statements Nts Pharma

Balance sheet of Nts Pharma

Company age:
Age:
10 y. 8 m. 2 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of NTS PHARMA

Year
2019
2020
2021
2022
2023
Total assets 687 666,04 313 738,29 337 140,76 929 579,79 996 395,95
A. Fixed assets 108 751,53 78 900,34 56 778,23 395 591,53 23 541,20
B. Current assets 578 914,51 234 837,95 280 362,53 533 988,26 972 854,75
C. Share capital contributions (basic funds) 0,00 0,00 0,00 - -
D. Own shares (stocks) 0,00 0,00 0,00 - -
Total liabilities 687 666,04 313 738,29 337 140,76 929 579,79 996 395,95
A. Equity 179 674,80 -34 927,37 153 508,65 157 186,10 86 923,18
B. Liabilities and provisions for liabilities 507 991,24 348 665,66 183 632,11 772 393,69 909 472,77
I. Long-term liabilities 225 032,56 20 000,00 0,00 290 164,94 421 979,30
II. Short-term liabilities 282 958,68 328 665,66 183 632,11 482 228,75 487 493,47
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.